Development code · Small Molecule
CTC-501
CTC-501 is a development code for ALTO-207, developed by Alto Neuroscience, Inc..
- Status
- Phase 2 for Treatment-resistant depression
- Mechanism
- D3 Agonist
- Developer
- Alto Neuroscience, Inc.
Programs
- ALTO-207 for Treatment-resistant depressionPhase 2Recruiting
Also known as
- ALTO-207
- pramipexole/ondansetron
- pramipexole
- ondansetron